UK Imaging Diabetes Study Seeing Diabetes Clearly

Launched by PERSPECTUM · Sep 24, 2021

Keywords

ClinConnect Summary

This will be a multi-site study adopting a prospective, observational cohort study design. There will be no intervention to the standard of care. Study participants will be enrolled in this study for a total of 5 years, with only 1 month of active participation. Participants will be required to attend a screening visit and 2 study visits. The screening visit will involve a medical review and receiving informed consent based on the participant information leaflet already communicated to the patient, pre-screening. The first study visit- baseline (visit 1) - will involve anthropometric measur...

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Male or female at least 18 years of age and diagnosed with type 2 diabetes, with or without diabetic retinopathy.
• • Participant willing and able to give informed consent for participation in the study.
• Exclusion Criteria:
• In 12 months prior to consent, evidence of existing cardiovascular event defined as at least one of:
• • myocardial infarction
• • ischaemic stroke
• • hospital admission/discharge for unstable angina
• • heart surgery
• • unstable angina
• • transient ischemic attack
• • The participant may not enter the study if they have any contraindication to magnetic resonance imaging (standard MR exclusion criteria including pregnancy, extensive tattoos, pacemaker, shrapnel injury, severe claustrophobia).
• • Patients with known autoimmune hepatitis, viral hepatitis, Wilson's disease or known significant structural renal tract abnormality.
• • Patients with known alcohol dependency.
• • Any other cause, including a significant disease or disorder which, in the opinion of the investigator, may either put the participant at risk because of participation in the study, or may influence the participant's ability to participate in the study